Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 3
1984 3
1985 5
1986 1
1987 2
1988 4
1989 4
1990 4
1991 10
1992 8
1993 10
1994 25
1995 16
1996 22
1997 17
1998 18
1999 15
2000 26
2001 28
2002 28
2003 38
2004 42
2005 63
2006 73
2007 78
2008 91
2009 115
2010 134
2011 184
2012 187
2013 257
2014 348
2015 375
2016 370
2017 370
2018 457
2019 487
2020 618
2021 695
2022 810
2023 345

Text availability

Article attribute

Article type

Publication date

Search Results

5,721 results

Results by year

Filters applied: . Clear all
Page 1
Metabolomics in rheumatoid arthritis: Advances and review.
Xu L, Chang C, Jiang P, Wei K, Zhang R, Jin Y, Zhao J, Xu L, Shi Y, Guo S, He D. Xu L, et al. Among authors: he d. Front Immunol. 2022 Aug 11;13:961708. doi: 10.3389/fimmu.2022.961708. eCollection 2022. Front Immunol. 2022. PMID: 36032122 Free PMC article. Review.
PCSK9 Inhibition: From Current Advances to Evolving Future.
Liu C, Chen J, Chen H, Zhang T, He D, Luo Q, Chi J, Hong Z, Liao Y, Zhang S, Wu Q, Cen H, Chen G, Li J, Wang L. Liu C, et al. Among authors: he d. Cells. 2022 Sep 23;11(19):2972. doi: 10.3390/cells11192972. Cells. 2022. PMID: 36230934 Free PMC article. Review.
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy.
Zhang Z, Cheng L, Li J, Qiao Q, Karki A, Allison DB, Shaker N, Li K, Utturkar SM, Atallah Lanman NM, Rao X, Rychahou P, He D, Konieczny SF, Wang C, Shao Q, Evers BM, Liu X. Zhang Z, et al. Among authors: he d. Cancer Res. 2022 Oct 4;82(19):3532-3548. doi: 10.1158/0008-5472.CAN-22-0018. Cancer Res. 2022. PMID: 35950917 Free PMC article.
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Gu W, Han W, Luo H, Zhou F, He D, Ma L, Guo H, Liang C, Chong T, Jiang J, Chen Z, Wang Y, Zou Q, Tian Y, Xiao J, Huang J, Zhu S, Dong Q, Zhang X, Li H, Yang X, Chen C, Li J, Jin C, Zhang X, Ye D; CHART Investigators. Gu W, et al. Among authors: he d. Lancet Oncol. 2022 Oct;23(10):1249-1260. doi: 10.1016/S1470-2045(22)00507-1. Epub 2022 Sep 5. Lancet Oncol. 2022. PMID: 36075260 Clinical Trial.
Photonic Nanojet-Mediated Optogenetics.
Guo J, Wu Y, Gong Z, Chen X, Cao F, Kala S, Qiu Z, Zhao X, Chen JJ, He D, Chen T, Zeng R, Zhu J, Wong KF, Murugappan S, Zhu T, Xian Q, Hou X, Ruan YC, Li B, Li YC, Zhang Y, Sun L. Guo J, et al. Among authors: he d. Adv Sci (Weinh). 2022 Sep;9(27):e2204667. doi: 10.1002/advs.202204667. Adv Sci (Weinh). 2022. PMID: 36150220 Free PMC article. No abstract available.
5,721 results